| Literature DB >> 27104959 |
Alessandra Ravidà1, Allison M Aldridge1, Nicole N Driessen2, Ferry A H Heus2, Cornelis H Hokke2, Sandra M O'Neill1.
Abstract
Fascioliasis, caused by theEntities:
Mesh:
Substances:
Year: 2016 PMID: 27104959 PMCID: PMC4841591 DOI: 10.1371/journal.pntd.0004601
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1FhTeg preparation is rich in oligomannose and truncated complex type N-glycans carrying fucose or sulfate/phosphate moieties.
Fh tegumental antigens were digested with trypsin followed by PNGase F treatment. Released N-glycans were subsequently labelled with 2-AA and analysed by MALDI-TOF-MS in the negative ion-reflector mode. Signals are labelled with monoisotopic masses. Most abundant N-glycan structures are annotated in the spectrum while minor peaks are reported in the supplementing material (S1 Table). The signal at m/z 1582.8 [M-H]- is annotated according to MALDI-TOF/TOF-MS analysis.
Fig 2FhTeg N-glycans carry core fucose and are sulphated/phosphorylated on terminal N-acetylglucosamine and mannose residues.
The sulphated/phosphorylated glycan observed at m/z 1313.6 [M-H]- in Fig 1 was analysed by MALDI-TOF- MS/MS. Differences in monosaccharides and functional groups content are indicated by double headed arrows.
Fig 3Mannose-rich oligosaccharides are predominantly localized on scales and suckers of adult flukes.
High mannose type N-glycans are highly expressed on FhTeg as visualised in ConA fluorescence micrographs (A-D) and ConA blot (E) of adult Fasciola hepatica tegumental coat. A-D: Oral (OS) and Ventral (VS) suckers (A and B, respectively), tegumental spines (C-D) probed with fluorescein-labelled ConA (green); Scale bars: 200μm (A-B), 100μm (C), 50μm (D); spinelets details highlighted with arrows. E: Tegumental proteins (15μg) probed with biotin-labelled ConA/IR-labelled streptavidin complex (green), MW marker (Red).
Fig 4FhTeg binding to dendritic cells is mediated by MR and is carbohydrate and calcium dependent.
A-B: MR-transfected CHO cells (A) and BMDCs (B) were stimulated with and without inhibitors, i.e. EGTA (10mM), anti-MR (1 μg ml-1), mannan (A: 100 μg ml-1;B: 1 mg/mL), GalNAc-4S (A: 1mM; B: 25 mM), for 45 min prior to stimulation with fluorescently labelled FhTeg (A: 1–10 μg ml-1; B: 5 μg/mL) for 45 min. Fluorescently labelled BSA was also used as control. FhTeg binding to cells was assessed by flow cytometry and reported in bar chart format. Data shown is the mean ± SD of one representative experiment; the experiment was repeated 2–3 times, **, p ≤ 0.01; ***, p ≤ 0.001 compared to FhTeg. C-D: BMDCs were stimulated with fluorescently labelled FhTeg (10μg ml-1, green) or BSA (10g ml-1, green)) for 45 min prior to paraformaldehyde fixation and mounting with DAPI (blue); Scale bar: 25μm.
Fig 5The immune properties of FhTeg are independent of the MR receptor.
A: BMDCs were stimulated with mannan for 30 min prior to incubation with FhTeg for 2.5 h. Total RNA was extracted, and after reverse transcription cDNA was analyzed with qPCR for SOCS3. RNA expression was normalized to GAPDH and actin control genes. B: BMDCs were pre-incubated with mannan prior stimulation with PBS or FhTeg (10μg) before addition of LPS (100ng ml-1) for 18 h. IL12p70 levels were measured with commercial ELISA kits. Data are presented as the mean ± SEM of two independent experiments. ***p ≤ 0.001; ****p ≤ 0.0001 compared to LPS group. C,D: BMDCs isolated from MR-knockout mice were stimulated with fluorescently labelled FhTeg or BSA (10μg ml-1, green) for 45 min prior to paraformaldehyde fixation. FhTeg binding to cells was assessed by flow cytometry and reported in bar chart format. E: BMDCs isolated from MR-knockout mice were stimulated with FhTeg (10μg) for 2.5 h. Total RNA was extracted, and after reverse transcription cDNA was analyzed with qPCR for SOCS3. RNA expression was normalized to GAPDH and actin control genes. F. BMDCs derived from MR knockout mice were stimulated with PBS or FhTeg (10μg) before addition of LPS (100ng ml-1) for 18 h. IL12p70 levels were measured with commercial ELISA kits. Data are presented as the mean ± SEM of two independent experiments. *p ≤ 0.05, **, p ≤ 0.01; ***, p ≤ 0.001.
Fig 6MALDI-FT-ICR-MS analysis of FhTeg N-glycans indicates the presence of phosphorylated glycan species.
A: FT-ICR-MS spectrum indicating the phosphorylated glycans identified by accurate mass determination with external calibration and additional comparison with the internal confirmed oligomannose glycans. B: Zoom region showing the high resolution separation between the Man6GlcNAc2 glycan and a phosphorylated glycan of almost identical mass. C: The scatter plot indicates the deviation of the measured m/z from the calculated m/z of phosphorylated glycans in comparison with hypothetical sulphated glycans and the oligomannosyl glycans also present in the spectrum.
Fig 7FhTeg–induced upregulation of SOCS3 transcription levels is reversed by anionic monosaccharide inhibitor GalNAc-4S and not Man-6P.
A,C: BMDCs were pre-incubated with Man-6P (A) or GalNAc-4S (C) prior stimulation with PBS or FhTeg (10μg) before addition of LPS (100ng ml-1) for 18 h. IL12p70 levels were measured with commercial ELISA kits. Data are presented as the mean ± SEM of two independent experiments. ***p ≤ 0.001; ****p ≤ 0.0001 compared to LPS group. B,D: BMDCs were stimulated with Man-6P (B) or GalNAc-4S (D) for 30 min prior to incubation with FhTeg for 2.5 h. Total RNA was extracted, and after reverse transcription cDNA was analyzed with qPCR for SOCS3. RNA expression was normalized to GAPDH and actin control genes. C: BMDCs were stimulated with GalNAc-4S for 30 min prior to incubation with FhTeg for 2.5 h. Total RNA was extracted, and after reverse transcription cDNA was analyzed with qPCR for SOCS3. RNA expression was normalized to GAPDH and actin control genes.